Medite Cancer Diagnostics, Inc.
Medite Cancer Diagnostics, Inc. (MDIT) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mdit · pe ratio · data through Dec 31, 2017
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Medite Cancer Diagnostics, Inc. (MDIT) measures how much investors pay for each dollar of the company's trailing earnings. MDIT's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.26.
Source: FMP · /ratios-ttm · /analyst-estimates · 2017-12-31
PE Ratio History
2015 – 2017 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Medite Cancer Diagnostics, Inc.You MDIT | $0M | N/A | — | -$0.26 |
 American Scientific Resources, Incorporated ASFX | $0M | N/A | — | — |
 Ceres Ventures, Inc. CEVE | $0M | N/A | — | -$0.01 |
 Fiore Cannabis Ltd. FIORF | $0M | N/A | — | -$0.06 |
 Healthcare Solutions Management Group, Inc. HSMD | $0M | N/A | — | -$0.49 |
 Lowell Farms Inc. LOWLF | $0M | N/A | — | -$2.71 |
 RenovaCare, Inc. RCAR | $0M | N/A | — | -$0.05 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2017-12-31Latest FY2017 | — | $-0.26 | — | |
2016-12-31 FY2016 | — | $-0.10 | — | |
2015-12-31 FY2015 | — | $-0.04 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Medite Cancer Diagnostics, Inc. (MDIT) measures how much investors pay for each dollar of the company's trailing earnings. MDIT's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.26.
Frequently asked questions
MDIT pe ratio · 6 questionsMDIT's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.26. Data sourced from Financial Modeling Prep via MDIT's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Medite Cancer Diagnostics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09